Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biocryst, Biontech, BMS, Exelixis, GC, GW, Harbour, Incyte, Opko Health, Pfizer, PTC, Regeneron, Roche, Sarepta, Tricida.